CASI Pharmaceuticals, Inc. (CASIF) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $5.63M | -58.2% |
| 2024 | $13.47M | -21.2% |
| 2023 | $17.08M | -63.7% |
| 2022 | $47.11M | +21.7% |
| 2021 | $38.70M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $5.63M | -58.2% |
| 2024 | $13.47M | -21.2% |
| 2023 | $17.08M | -63.7% |
| 2022 | $47.11M | +21.7% |
| 2021 | $38.70M | — |